Cullinan Oncology LLC Cash Flow Quality Index
Cullinan Oncology LLC cash flow quality index. Cullinan Oncology LLC (CGEM) has a Cash Flow Quality Index of -0.15x as of June 2022. Operating cash flow of $-25.42 Million is below net income of $174.90 Million, suggesting accrual-heavy earnings not yet converted to cash. See CGEM financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Cullinan Oncology LLC (2022–2022)
Cash flow quality index of Cullinan Oncology LLC from 2022 to 2022. Historical Cash Flow Quality Index for Cullinan Oncology LLC across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore CGEM operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cullinan Oncology LLC Cash Flow Quality Index by Year (2022–2022)
Cullinan Oncology LLC cash flow quality index by year from 2022 to 2022. Year-by-year earnings quality comparison for Cullinan Oncology LLC. For the full cash flow conversion analysis, see CGEM cash flow metrics.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -1.16x | $-126.66 Million | $109.19 Million | — |